![Toward Building a Provincial Diabetes Registry of Children and Youth Living With Diabetes in British Columbia, Canada - Canadian Journal of Diabetes Toward Building a Provincial Diabetes Registry of Children and Youth Living With Diabetes in British Columbia, Canada - Canadian Journal of Diabetes](https://www.canadianjournalofdiabetes.com/cms/asset/6be1304d-a134-4df4-8181-6381947d82f0/gr1.jpg)
Toward Building a Provincial Diabetes Registry of Children and Youth Living With Diabetes in British Columbia, Canada - Canadian Journal of Diabetes
![Randomized Comparison of Initiating the Fixed-Ratio Combination of iGlarLixi or Biosimilar Insulin Glargine Together With Gliclazide in Participants of South Asian Origin With Type 2 Diabetes: VARIATION 2 SA Trial - ScienceDirect Randomized Comparison of Initiating the Fixed-Ratio Combination of iGlarLixi or Biosimilar Insulin Glargine Together With Gliclazide in Participants of South Asian Origin With Type 2 Diabetes: VARIATION 2 SA Trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1499267122000156-gr1.jpg)
Randomized Comparison of Initiating the Fixed-Ratio Combination of iGlarLixi or Biosimilar Insulin Glargine Together With Gliclazide in Participants of South Asian Origin With Type 2 Diabetes: VARIATION 2 SA Trial - ScienceDirect
![Randomized Comparison of Initiating the Fixed-Ratio Combination of iGlarLixi or Biosimilar Insulin Glargine Together With Gliclazide in Participants of South Asian Origin With Type 2 Diabetes: VARIATION 2 SA Trial - ScienceDirect Randomized Comparison of Initiating the Fixed-Ratio Combination of iGlarLixi or Biosimilar Insulin Glargine Together With Gliclazide in Participants of South Asian Origin With Type 2 Diabetes: VARIATION 2 SA Trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1499267122000156-figs2.jpg)
Randomized Comparison of Initiating the Fixed-Ratio Combination of iGlarLixi or Biosimilar Insulin Glargine Together With Gliclazide in Participants of South Asian Origin With Type 2 Diabetes: VARIATION 2 SA Trial - ScienceDirect
![La RAMQ prend maintenant en charge le système Dexcom G6 de surveillance du glucose en continu pour les personnes atteintes de diabète de type 1 au Québec La RAMQ prend maintenant en charge le système Dexcom G6 de surveillance du glucose en continu pour les personnes atteintes de diabète de type 1 au Québec](https://mma.prnewswire.com/media/1518550/Dexcom__Inc__La_RAMQ_prend_maintenant_en_charge_le_syst_me_Dexco.jpg?p=facebook)
La RAMQ prend maintenant en charge le système Dexcom G6 de surveillance du glucose en continu pour les personnes atteintes de diabète de type 1 au Québec
![LA NOUVELLE GÉNÉRATION DU SYSTÈME DEXCOM G7 DE SURVEILLANCE CONTINUE DU GLUCOSE EST MAINTENANT OFFERTE AU CANADA | Business Wire LA NOUVELLE GÉNÉRATION DU SYSTÈME DEXCOM G7 DE SURVEILLANCE CONTINUE DU GLUCOSE EST MAINTENANT OFFERTE AU CANADA | Business Wire](https://mms.businesswire.com/media/20231005777215/fr/1907552/5/dexcom-g7-sensor-apple-iphone-7.2-mmol_FR.jpg)